Validation of a specific quality of life questionnaire for functional digestive disorders

Gut

Volumn 44, Issue 4, 1999, Pages 527-533

  Chassany, O ^a   Marquis, P ^b   Scherrer, B ^c   Read, N W ^d   Finger, T ^e   Bergmann, J F ^a   Fraitag, B ^c   Geneve, J ^c   Caulin, C ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b MAPI VALUES   (United States)

^c Institut de Recherche Jouveinal   (France)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

^e Quali Team   (Germany)

Author keywords

Clinical trial; Digestive disorders; Dyspepsia; Irritable bowel syndrome; Quality of life; Validation

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DYSPEPSIA; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SELF REPORT; VALIDATION PROCESS;

EID: 0032902430     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.4.527     Document Type: Article

References (34)

1. Farthing MJG. Irritable bowel, irritable body, or irritable brain? BMJ 1995;310:171-5.
2. Talley NJ. Functional dyspepsia: should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995;9:107-15
3. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.
4. Wiklund I, Dimenäs E, Wahl M. Factors of importance when evaluating quality of life in clinical trials. Control Clin Trials 1990;11:169-79.
5. Testa MA, Simonson DC. Assessment of quality of life outcomes. N Engl J Med 1996;334:835-40.
6. Drossman DA, Li Z, Andruzzi E, et al. Householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
7. Talley NJ, Weaver AL, Zinsmeister AR. Impact of functional dyspepsia on quality of life. Dig Dis Sci 1995;40:584-9.
8. Chassany O, Bergmann JF, Billardon M, et al. Quality of life in irritable bowel syndrome [abstract]. Gastroenterology 1996;110:A646.
9. Staquet M, Berzon R, Osoba D, et al. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res 1996;5:496-500.
10. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27(suppl):S217-32.
11. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Control Clin Trials 1991;12:S142-58.
12. Chassany O, Geneve J, Abitbol JL, et al. Specific quality of life questionnaire in irritable bowel syndrome. Effect of fedotozine [abstract]. Gastroenterology 1995;108:A581.
13. Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterology International 1991;4:145-60.
14. Thompson WG, Creed F, Drossman DA, et al. Functional bowel disease and functional abdominal pain. Gastroenterology International 1992;5:75-91.
15. Aaronson NK, Acquadro C, Alonso J, et al. International quality of life assessment (IQOLA) project. Qual Life Res 1992;1:349-51.
16. Fletcher A, Gore S, Jones D, et al. Quality of life measures in health care. II. Design, analysis, and interpretation. BMJ 1992;305:1145-8.
17. Marquis P, Fayol C, Joire JE, et al. Psychometric properties of a specific quality of life questionnaire in angina pectoris patients. Qual Life Res 1995;4:540-6.
18. Aaronson NK. Quality of life assessment in clinical trials: methodologic issues. Control Clin Trials 1980;10:S195-208.
19. Agréus L, Svärsudd K, Nyren O, et al. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1995;109:671-80.
20. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
21. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996;10:83-9.
22. Talley NJ, Fett SL, Zinsmeister AR, et al. Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology 1994;107:1040-9.
23. Wilhelmsen I. Quality of life in upper gastrointestinal disorders. Scand J Gastroenterol 1995;211:21-5.
24. Wiklund I, Glise H, Lauritsen K, et al. A placebo-controlled comparison of the effectiveness of omeprazole in relieving dyspeptic symptoms and improving quality of life in patients with functional dyspepsia [abstract]. Gastroenterology 1997;112:A330.
25. O'Sullivan M, Mahmud N, Lovett E, et al. Impaired quality of life in irritable bowel syndrome as compared to inflammatory bowel disease. Gut 1996;39(suppl 3):A33.
26. Danquechin Dorval E, Delvaux M, et al. Profil et évolution du syndrome de l'intestin irritable. Gastroenterol Clin Biol 1994;18:145-50.
27. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-68.
28. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and non patients with irritable bowel syndrome. Gastroenterology 1988;95:701-8.
29. Trus TL, Laycock WS, Branum GD, et al. Quality of life scores correlate poorly with subjective and objective measurements of gastroesophageal reflux [abstract]. Gastroenterology 1997;112:A1480.
30. Talley NJ, Phillips SF, Bruce B, et al. Relation among personality and symptoms in non-ulcer dyspepsia and the irritable bowel syndrome. Gastroenterology 1990;99:327-33.
31. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10.
32. Guthrie EA, Creed FH, Whorwell PJ, et al. Outpatients with irritable bowel syndrome: a comparison of first and chronic attenders. Gut 1992;33:361-3.
33. Dimenäs E, Carlsson G, Glise H, et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996;31(suppl 221):8-13.
34. Hahn BA, Kirschdoefer J, Fullerton S, et al. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther 1997;11:547-52.